Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ronen

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Metabolites|March 6, 2021
Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in GliomaMarina Radoul, Donghyun Hong, Anne Marie Gillespie, et al.
Cancer & Metabolism|April 6, 2018
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent mannerPavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 19, 2010
Multiple levels of gene regulation mediate differentiation of the intracellular pathogen LeishmaniaT Lahav, D Sivam, H Volpin, et al.
Oncotarget|May 5, 2016
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transportersPavithra Viswanath, Chloe Najac, Jose L Izquierdo-Garcia, et al.
Neurology|April 5, 2015
Children's perspective of quality of life in epilepsyNora Fayed, Aileen M Davis, David L Streiner, et al.
Cancer Research|October 17, 2014
Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cellsIlwoo Park, Joydeep Mukherjee, Motokazu Ito, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 7, 2019
Parent Proxy Discrepancy Groups of Quality of Life in Childhood EpilepsyNora Fayed, Lisa Avery, Aileen M Davis, et al.
Scientific Reports|July 21, 2019
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survivalGeorgios Batsios, Pavithra Viswanath, Elavarasan Subramani, et al.
Neuro-Oncology|January 29, 2022
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomasCéline Taglang, Georgios Batsios, Joydeep Mukherjee, et al.
Theranostics|August 6, 2020
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade gliomaAbigail R Molloy, Chloé Najac, Pavithra Viswanath, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Metabolites|March 6, 2021
Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in GliomaMarina Radoul, Donghyun Hong, Anne Marie Gillespie, et al.
Cancer & Metabolism|April 6, 2018
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent mannerPavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 19, 2010
Multiple levels of gene regulation mediate differentiation of the intracellular pathogen LeishmaniaT Lahav, D Sivam, H Volpin, et al.
Oncotarget|May 5, 2016
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transportersPavithra Viswanath, Chloe Najac, Jose L Izquierdo-Garcia, et al.
Neurology|April 5, 2015
Children's perspective of quality of life in epilepsyNora Fayed, Aileen M Davis, David L Streiner, et al.
Cancer Research|October 17, 2014
Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cellsIlwoo Park, Joydeep Mukherjee, Motokazu Ito, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 7, 2019
Parent Proxy Discrepancy Groups of Quality of Life in Childhood EpilepsyNora Fayed, Lisa Avery, Aileen M Davis, et al.
Scientific Reports|July 21, 2019
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survivalGeorgios Batsios, Pavithra Viswanath, Elavarasan Subramani, et al.
Neuro-Oncology|January 29, 2022
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomasCéline Taglang, Georgios Batsios, Joydeep Mukherjee, et al.
Theranostics|August 6, 2020
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade gliomaAbigail R Molloy, Chloé Najac, Pavithra Viswanath, et al.
Pageof 22